INTESTINE Vol.21 No.3(8)

Theme New evolvement in treatment for early rectal cancer
Title Early rectal cancer treatment with taTME
Publish Date 2017/05
Author Suguru Hasegawa Department of Gastroenterological Surgery, Fukuoka University
Author Yasuhiro Hashimoto Department of Gastroenterological Surgery, Fukuoka University
Author Ryo Nakashima Department of Gastroenterological Surgery, Fukuoka University
Author Hideki Nagano Department of Gastroenterological Surgery, Fukuoka University
Author Taisuke Matsuoka Department of Gastroenterological Surgery, Fukuoka University
Author Akira Komono Department of Gastroenterological Surgery, Fukuoka University
Author Ryohei Sakamoto Department of Gastroenterological Surgery, Fukuoka University
Author Naoya Aisu Department of Gastroenterological Surgery, Fukuoka University
Author Daibo Kojima Department of Gastroenterological Surgery, Fukuoka University
Author Yoichiro Yoshida Department of Gastroenterological Surgery, Fukuoka University
[ Summary ] Total mesorectal excision (TME) is a standard surgical treatment for resectable rectal cancer. Although laparoscopic surgery is gaining acceptance, dissection and transection of the rectum in deep pelvis locations is not always easy, especially in patients with a narrow pelvis or bulky tumors. Recently, transanal TME (taTME) has been introduced in Western countries, where rectal transection and dissection is performed transanally using single port surgery techniques. There are several benefits to using taTME as opposed to laparoscopic TME, including reliable determination of distal margins and facilitation of rectal dissection even in patients with narrow pelvises or bulky tumors. Two large randomized controlled studies comparing laparoscopic TME and taTME are under way to test the true benefits of this approach. Special care should be taken not to injure the urethra or pelvic autonomic nerves because dissection can easily go outside of the TME plane with this approach.
back